| Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a … M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ... The Lancet 394 (10214), 2096-2107, 2019 | 651* | 2019 |
| Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ... The Lancet Haematology 7 (2), e157-e167, 2020 | 448 | 2020 |
| Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 51 (7), 906-912, 2016 | 440 | 2016 |
| Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 50 (6), 781-789, 2015 | 397 | 2015 |
| NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules M Gunay-Aygun, TC Falik-Zaccai, T Vilboux, Y Zivony-Elboum, F Gumruk, ... Nature genetics 43 (8), 732-734, 2011 | 284 | 2011 |
| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ... The Lancet 397 (10292), 2361-2371, 2021 | 283 | 2021 |
| The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies JR Passweg, H Baldomero, GW Basak, C Chabannon, S Corbacioglu, ... Bone marrow transplantation 54 (10), 1575-1585, 2019 | 196 | 2019 |
| Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans S Durdu, AR Akar, M Arat, T Sancak, NT Eren, U Ozyurda Journal of vascular surgery 44 (4), 732-739, 2006 | 191 | 2006 |
| Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group … A Tichelli, J Passweg, D Wójcik, A Rovó, JL Harousseau, T Masszi, ... haematologica 93 (8), 1203-1210, 2008 | 183 | 2008 |
| Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p M Gunay-Aygun, Y Zivony-Elboum, F Gumruk, D Geiger, M Cetin, ... Blood, The Journal of the American Society of Hematology 116 (23), 4990-5001, 2010 | 166 | 2010 |
| Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies R Idilman, M Arat, E Soydan, M Törüner, I Soykan, H Akbulut, Ö Arslan, ... Journal of viral hepatitis 11 (2), 141-147, 2004 | 112 | 2004 |
| Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis H Akan, N Güven, İ Ayogdu, M Arat, M Beksaç, K Dalva Acta haematologica 103 (3), 152-156, 2000 | 112 | 2000 |
| Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies H Celebi, H Akan, E Akçağlayan, C Üstün, M Arat Bone marrow transplantation 26 (2), 211-214, 2000 | 83 | 2000 |
| Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience H Bekoz, M Ozbalak, N Karadurmus, S Paydas, A Turker, T Toptas, ... Annals of Hematology 99, 2565-2576, 2020 | 81 | 2020 |
| Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert … M Mohty, F Malard, M Abecasis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 55 (3), 485-495, 2020 | 79 | 2020 |
| Late complications after hematopoietic stem cell transplantation A Tichelli, A Rovó, J Passweg, CP Schwarze, MT Van Lint, M Arat, ... Expert review of hematology 2 (5), 583-601, 2009 | 78 | 2009 |
| Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT Z DeFilipp, RF Duarte, JA Snowden, NS Majhail, DM Greenfield, ... Bone marrow transplantation 52 (2), 173-182, 2017 | 75 | 2017 |
| Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival I Kuzu, M Beksac, M Arat, H Celebi, AH Elhan, S Erekul Leukemia & lymphoma 45 (6), 1185-1190, 2004 | 72 | 2004 |
| Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute … A Nagler, M Labopin, M Houhou, M Aljurf, A Mousavi, RM Hamladji, ... Journal of Hematology & Oncology 14, 1-12, 2021 | 70 | 2021 |
| Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors P Topcuoglu, M Arat, K Dalva, M Özcan Bone marrow transplantation 33 (2), 171-176, 2004 | 61 | 2004 |
